Skip to content

Medical emergency? What to do

Glucagonoma - Pancreatic cancers

3-RXPublished January 20, 20084 min read

Key points

  • A glucagonoma is a pancreatic α-cell tumor that secretes glucagon, producing hyperglycemia and a characteristic skin rash.
  • Symptoms and Signs Because glucagonomas produce glucagon, the symptoms are the same as those of diabetes.
  • Treatment Resection of the tumor alleviates all symptoms.
  • An excellent review of incidence, causes, and current management of anal cancer.

A glucagonoma is a pancreatic α-cell tumor that secretes glucagon, producing hyperglycemia and a characteristic skin rash. Diagnosis is by elevated glucagon levels and imaging studies. Tumor is localized with CT and endoscopic ultrasound. Treatment is surgical resection.

Glucagonomas are very rare but similar to other islet cell tumors in that the primary and metastatic lesions are slow-growing: 15-yr survival is common. Eighty percent of glucagonomas are malignant. The average age at symptom onset is 50 yr; 80% of patients are women. A few patients have multiple endocrine neoplasia type I.

Symptoms and Signs
Because glucagonomas produce glucagon, the symptoms are the same as those of diabetes. Frequently, weight loss, normochromic anemia, hypoaminoacidemia, and hypolipidemia are present, but the most distinctive clinical feature is a chronic eruption involving the extremities, often associated with a smooth, shiny, vermilion tongue and cheilitis. The exfoliating, brownish red, erythematous lesion with superficial necrolysis is termed necrolytic migratory erythema.

Diagnosis
Most patients with glucagonoma have glucagon levels > 1000 pg/mL (normal < 200). However, moderate elevations occur in renal insufficiency, acute pancreatitis, severe stress, and fasting. Correlation with symptoms is required. Patients should have abdominal CT followed by endoscopic ultrasound; MRI may be used if CT is unrevealing.

Treatment
Resection of the tumor alleviates all symptoms. Unresectable, metastatic, or recurrent tumors are treated with combination streptozocin and doxorubicin, which may decrease levels of circulating immunoreactive glucagon, lessen symptoms, and improve response rates (50%) but are unlikely to improve survival. Octreotide injections partially suppress glucagon production and relieve the erythema, but glucose tolerance may also decrease because octreotide decreases insulin secretion. Octreotide may quickly reverse anorexia and weight loss caused by the catabolic effect of glucagon excess. Patients who respond may be converted to a long-acting octreotide formulation administered 20 to 30 mg IM once/mo. Patients using octreotide may also need to take supplemental pancreatic enzymes because octreotide suppresses pancreatic enzyme secretion.

Locally applied, oral, or parenteral zinc may cause the erythema to disappear, but resolution may occur after simple hydration or IV administration of amino or fatty acids, suggesting that the erythema is not solely caused by zinc deficiency.

Eric J. Szilagy, MD and Asim Farid, MD, FRCS(Edin)
Current Treatment Options in Gastroenterology 2001, 4:275-279
Current Medicine Group LLC ISSN 1092-8472

BIBLIOGRAPHY
1. Ryan D: Carcinoma of the anal canal. N Engl J Med 2000, 342:792-800.
An excellent review of incidence, causes, and current management of anal cancer.

2. Klas J: Malignant tumors of the anal canal. The spectrum of disease, treatment and outcome. Cancer 1999, 85:1686-1693.
A comprehensive study and discussion of anal cancer.

3. Deans GT: Malignant anal tumours. Br J Surg 1994, 81:500-508.

4. Faynsod M, et al.: Patterns of recurrence in anal canal carcinoma. Arch Surg 2000, 135:1090-1095.
A long-term review comparing surgery with chemoradiation, which advocates aggressive surgery for patients with recurrent or residual disease.

5. International Union Against Cancer: TNM Classification of Malignant Tumors. Edited by Hermanek P, Sobin LH. New York: Springer-Verlag; 1987.

6. American Joint Committee on Cancer.: Manual for Staging of Cancer. Philadelphia: J B Lippincott; 1987.

7. Morson BC: International Histological Classification of Tumors, No 15. Geneva: World Health Organization; 1976.

8. Nigro ND: Multidisciplinary management of carcinoma of the anus. World J Surg 1987, 11:446-451.

9. Nigro ND: Combined therapy for cancer of the anal canal. A preliminary report. Dis Colon Rectum 1974, 17:354-356.

10. Stafford SL: Combined radiation and chemotherapy for carcinoma of the anal canal. Oncology 1998, 12:373-381.

11. Cleator S, et al.: Treatment of HIV associated invasive anal cancer with combined chemoradiation. Eur J Cancer 2000, 36:754-758.

12. Zelnick R: Results of abdominoperineal resection for failures after combination chemotherapy and radiation therapy for anal canal cancers. Dis Colon Rectum 1992, 35:574-578.

13. Doci R, et al.: Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 1996, 14:3121-3125.

14. Martenson JA: External radiation therapy without chemotherapy in the management of anal cancer. Cancer 1993, 71:1736-1740.

15. Mendenhall WM: Squamous cell cancer of the anal margin. Oncology 1996, 10:1843-1848.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Tumors of the Gastrointestinal tract

Esophageal tumor

The most common malignant esophageal tumor is squamous cell carcinoma, followed by adenocarcinoma. Symptoms are progressive dysphagia and weight loss. Diagnosis is by endoscopy, followed by CT and endoscopic…

10 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.